RANI READ THE FULL RANI RESEARCH REPORT On February 5 th , Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) shared its preclinical readout from the RT-116 study demonstrating successful oral delivery of ...

reducing food intake and having trophic effects on the pancreatic islet cells. [9] These incretin hormones have been implicated recently in the pathogenesis of Type 2 diabetes. GLP-1 is ...

A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...

Side effects of compounded drugs can include potential ... Semaglutide belongs to a class of drugs called incretin mimetics, which imitate gut hormones aiding in blood sugar regulation.

Proceeds will support testing of drugs designed to suppress hunger in people with the tough-to-treat rare disease and, ...

‘Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial’ by Christian S. Hendershot et al. was published in JAMA Psychiatry at 16:00 UK time on Wednesday 12 February ...

It also showed that the drug was well tolerated, with side effects mainly gastrointestinal complaints like nausea and diarrhoea that are typical of this type of incretin-based therapy, according ...

The data, published in JAMA Psychiatry, add to the growing body of evidence supporting the use of GLP-1 receptor agonists for ...

Palatin Technologies, Inc. (AMEX: PTN) Q2 2025 Earnings Call Transcript February 13, 2025 ...

Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

People with pockets of fat hidden inside their muscles are at a higher risk of dying or being hospitalised from a heart attack or heart failure, regardless of their body mass index, according to ...